You are here: Industry Insights > litigation

News List

Bayer faces second investor reckoning over glyphosate litigation expresspharma
April 29, 2020
Criticism from investors at this year’s annual shareholders’ meeting – held in a virtual format with gatherings banned due to the coronavirus – will likely be less scathing than it was in 2019.
Natco Pharma settles patent litigation with Onyx Therapeutics over cancer drug expressbpd
May 31, 2019
The company said it has reached a settlement agreement with Onyx Therapeutics related to generic versions of 10 mg, 30 mg and 60 mg of Kyprolis
Patent litigation for adalimumab resolved in the US europeanpharmaceuticalreview
May 29, 2019
AbbVie has announced that it has resolved its US HUMIRA (adalimumab) litigation with Boehringer Ingelheim.
Endo breaks from the pack with opioid litigation settlement talks fiercepharma
September 12, 2018
Endo Pharmaceuticals has been settling litigation for hundreds of millions of dollars while it works to cut its $8 billion in debt.
Lilly used nursing services as kickbacks to boost insulin prescriptions, lawsuit claims fiercepharma
November 17, 2017
After Novo Nordisk settled a lawsuit alleging it marketed certain drugs under a "white coat" sales scheme, fellow diabetes drug giant Eli Lilly is facing similar claims of illicit marketing
Novo Nordisk settles lawsuit over illegal marketing practices for $58.7 million pharmafile
September 07, 2017
Novo Nordisk has resolved a probe by the US Justice Department which accused the Danish drugmaker of illegal marketing activities in the sale of its top selling product Victoza and other drugs from its diabetes portfolio.